Atticus H. Hainsworth

Also affiliated with St George’s University Hospitals NHS Foundation Trust

NeuroscienceMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Cerebral Small Vessel Disease, Hypertension, and Vascular Contributions to Cognitive Impairment and Dementia”.

Cerebral Small Vessel Disease, Hypertension, and Vascular Contributions to Cognitive Impairment and Dementia

Hypertension(2023)10.1161/hypertensionaha.123.19943

N/A

0.810DataRank · unranked

221 citations

Hugh S. Markus, Julie A. Schneider, Atticus H. Hainsworth

Clinical trials in vascular cognitive impairment following SPRINT-MIND: An international perspective

Cell Reports Medicine(2023)10.1016/j.xcrm.2023.101089

N/A

0.510DataRank · unranked

29 citations

Suvarna Alladi, Sandra E. Black, Jurgen A.H.R. Claassen, Charles DeCarli, Timothy M. Hughes +12 more

Collagen IV deficiency causes hypertrophic remodeling and endothelium-dependent hyperpolarization in small vessel disease with intracerebral hemorrhage

EBioMedicine(2024)10.1016/j.ebiom.2024.105315

N/A

0.489DataRank · unranked

25 citations

Cameron R Thomson, Laura Gonzalez-Trueba, Yuan Yan Sin, Alessandra Granata, Graham Hamilton +24 more

The promise of molecular science in brain health. What breakthroughs are anticipated in the next 20 years?

Cerebral Circulation - Cognition and Behavior(2024)10.1016/j.cccb.2024.100364

N/A

0.165DataRank · unranked

2 citations

Thomas P. Blackburn, Elizabeth M. Bradshaw, Fanny M. Elahi, Philip B. Gorelick, Jeremy D. Isaacs +3 more

The epidemiology is promising, but the trial evidence is weak. Why pharmacological dementia risk reduction trials haven't lived up to expectations, and where do we go from here?

Alzheimer s & Dementia(2021)10.1002/alz.12393

N/A

0DataRank · unranked

11 citations

Hiroko H. Dodge, Sarah‐Naomi James, Gregory A. Jicha, Pierre‐François Meyer, Marcus Richards +9 more

PDE5 inhibitor drugs for use in dementia

Alzheimer s & Dementia Translational Research & Clinical Interventions(2023)10.1002/trc2.12412

N/A

0DataRank · unranked

18 citations

Ottavio Arancio, Fanny M. Elahi, Jeremy D. Isaacs, Feixiong Cheng, Atticus H. Hainsworth